Vol. 19 No. 4 (2021): Blood Transfusion - 4 2021 (July-August)
Editorial
Original article
-
Mortality and clinical outcome of Italian patients undergoing orthopaedic surgery: effect of peri-operative blood transfusions
-
Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish tertiary care national reference centre
-
Hypoxia and hypocapnia storage of gamma-irradiated red cell concentrates
-
GSTP1 rs1695 and rs1871042, and SOD2 rs4880 as molecular markers of lipid peroxidation in blood storage
-
Molecular basis of serological weak D phenotypes and RhD typing discrepancies identified in the Korean population
-
Pain assessment and management in Italian haemophilia centres
-
Clinical evaluation of allogeneic eye drops from cord blood platelet lysate
Case report
Position paper
-
Position paper on the use of COVID-19 convalescent plasma: an update
-
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more